Podcasts about nanoscience

Voyageur Pharmaceuticals CEO Brent Willis joined Steve Darling from Proactive to announce the company has received a $600,000 grant from Alberta Innovates, a provincial Crown corporation and Alberta's largest research and innovation organization. The grant, awarded through the AICE-Market Access Program, is aimed at supporting the commercialization and market access of emerging health technologies in Alberta. Willis shared that the funds will be used for a pivotal study assessing the efficacy of Voyageur's Frances Creek barium sulfate compared to competing products. The study will focus on evaluating the performance of natural barite from Frances Creek against synthetic barium precipitate and oral iodine products. Currently, synthetic barium and diluted iodine contrast media dominate the fluoroscopy and Computed Tomography examination markets. Voyageur aims to highlight the superior imaging quality of its natural barium sulfate, attributed to its wider particle distribution. This research is expected to enhance the financial viability of the Frances Creek project and strengthen marketing strategies to drive sales growth. Willis also noted that Voyageur is in the testing and refinement phase for its five Health Canada licensed barium contrast products. The company is making steady progress toward its market launch, with a go-to-market plan that includes third-party barium sulfate imports and contract manufacturing partnerships. #proactiveinvestors #voyageurpharmaceuticalsltd #tsxv #vm #vyyrf #ctscan #xray #BrentWillis, #RainCage, #Nanoscience, #MRI, #CTScan, #MedicalBreakthrough, #Fullerenes, #Vanadium, #Gadolinium, #Bismuth, #Iodine, #Radiology, #MedicalInnovation, #DrugDevelopment, #Healthcare, #ScientificBreakthrough

Voyageur Pharmaceuticals CEO Brent Willis joined Steve Darling from Proactive to share details from a recently released Letter from the CEO, highlighting the company's significant achievements in 2024 and its ambitious plans for 2025. Willis reflected on 2024 as a transformative year for Voyageur, with the company entering into a Letter of Intent with a large multinational pharmaceutical company. This collaboration aims to improve production efficiencies and expand Voyageur's presence in the contrast media market. Both parties are actively working toward a definitive agreement, expected in early 2025. Voyageur introduced five new Health Canada-licensed barium contrast products aimed at raising the bar for medical imaging standards and enhancing diagnostic precision for healthcare professionals. This accomplishment followed 18 months of dedicated research and development. The company secured a $2.7 million sales distribution contract for its SmoothX 2% Barium Contrast product, solidifying its market presence in Latin America. Regulatory approvals are in progress, with sales slated to commence in the second half of 2025. Additionally, Voyageur is engaging with global distributors to broaden its reach. Voyageur is entering 2025 with a clear roadmap for advancing its product pipeline and market position, which includes extensive testing of its barium contrast formulations in human subjects is set to begin, with a focus on ensuring safety and efficacy in clinical settings. Voyageur aims to secure FDA approvals for its barium contrast products, demonstrating compliance with rigorous U.S. regulatory standards. A major initiative for 2025 involves advancing its iodine contrast drug development in the U.S. The goal is to produce the lowest-cost iodine contrast drugs in the market. Preliminary bench-scale testing has already commenced, and the company is laying the groundwork for full-scale production. With North America currently relying 100% on imported radiology drugs, Voyageur is focused on addressing critical mineral supply constraints. The company is working to establish the first secure, vertically integrated supply chain for radiology drugs in North America, aiming to fill critical gaps in the industry. As Willis explained, these efforts underscore Voyageur's commitment to innovation and its vision to redefine the radiology drug industry by providing secure, cost-effective, and high-quality solutions for healthcare professionals. With its robust pipeline and strategic partnerships, Voyageur is well-positioned for sustained growth and success in 2025 and beyond. #proactiveinvestors #voyageurpharmaceuticalsltd #tsxv #vm #vyyrf #ctscan #xray #BrentWillis, #RainCage, #Nanoscience, #MRI, #CTScan, #MedicalBreakthrough, #Fullerenes, #Vanadium, #Gadolinium, #Bismuth, #Iodine, #Radiology, #MedicalInnovation, #DrugDevelopment, #Healthcare, #ScientificBreakthrough,

Voyageur Pharmaceuticals CEO Brent Willis joined Steve Darling from Proactive to announce the commencement of human testing for the company's latest suite of barium contrast products, designed to optimize radiographic examinations of the gastrointestinal tract. The product lineup, including SmoothX, SmoothHD, SmoothLD, VisionHD, and VisionLD, is tailored to provide enhanced clarity, detail, and versatility for both adult and pediatric imaging applications. Willis emphasized the importance of this milestone, as it represents a critical step toward the company's goal of entering the Canadian market in 2025. The human testing process is being conducted in two phase with Phase 1 in Q1 2025 and will focus on assessing product performance based on key indicators such as imaging quality, diagnostic yield, contrast administration success rates, detection sensitivity, and patient safety. The company says some additional metrics will include patient satisfaction, procedure completion rates, adverse event rates, and compliance rates will also be closely monitored. These advanced formulations are designed to meet diverse clinical needs, ensuring high performance while maintaining safety and ease of use for patients. Voyageur aims to set a new standard in barium contrast agents, offering both precision and reliability in diagnostic imaging. This testing phase is an essential step in achieving regulatory approval and market readiness. #proactiveinvestors #voyageurpharmaceuticalsltd #tsxv #vm #vyyrf #ctscan #xray #BrentWillis, #RainCage, #Nanoscience, #MRI, #CTScan, #MedicalBreakthrough, #Fullerenes, #Vanadium, #Gadolinium, #Bismuth, #Iodine, #Radiology, #MedicalInnovation, #DrugDevelopment, #Healthcare, #ScientificBreakthrough,

Voyageur Pharmaceuticals CEO Brent Willis joined Steve Darling from Proactive to announce a significant milestone for the company: entering into a Letter of Intent (LOI) with a major multinational pharmaceutical company. This strategic collaboration is aimed at enhancing production efficiencies and expanding Voyageur's project portfolio within the contrast media industry. Willis explained that the proposed partnership is expected to accelerate Voyageur's development of vertically integrated production for its suite of contrast media products. The collaboration would also enable the company to expedite its entry into new segments of the contrast media market, positioning Voyageur for faster progress across its operations. The LOI serves as a precursor to a formal definitive agreement anticipated in the New Year. The agreement will define the full scope of the partnership, including the deal structure, project expectations, and timelines for achieving key milestones. Willis emphasized the importance of this collaboration, noting its potential to diversify Voyageur's product mix and drive forward the company's vision for growth in the pharmaceutical sector. This partnership marks a pivotal step in Voyageur's journey toward becoming a leading player in the contrast media industry. #proactiveinvestors #voyageurpharmaceuticalsltd #tsxv #vm #vyyrf #ctscan #xray #BrentWillis, #RainCage, #Nanoscience, #MRI, #CTScan, #MedicalBreakthrough, #Fullerenes, #Vanadium, #Gadolinium, #Bismuth, #Iodine, #Radiology, #MedicalInnovation, #DrugDevelopment, #Healthcare, #ScientificBreakthrough, #VoyageurPharmaceuticals #MedicalImaging #BrentWillis #FDAApproval #ContrastMedia #HealthCanada #PharmaceuticalInnovation #2025Milestones #DiagnosticsMarket #ProactiveInvestors

Voyageur Pharmaceuticals CEO Brent Willis joined Steve Darling from Proactive to announce the successful completion of formulation work for the company's latest product line, which includes five Health Canada-licensed products. These advanced formulations are set to raise industry standards, offering enhanced value to healthcare providers and stakeholders. Willis also revealed the launch of two new product brands, Vision and Smooth barium contrast agents, aimed at improving versatility and performance in medical diagnostics. Classified as new drugs, these innovative products are poised to benefit from faster approval processes, significantly reducing costs and timelines compared to traditional New Drug Application (NDA) submissions. This move marks a shift away from generics, positioning Voyageur Pharmaceuticals as a more competitive force in the market. Voyageur has already completed several pilot test batches for its product suite and is now advancing to patient testing. The company is entering the final phase of clinical trials, where these products will be used in X-ray and Computed Tomography procedures, signaling significant progress toward full market deployment. Additionally, the company has appointed Dr. Iryna Saranchova as its new Chief Science Officer, pending regulatory approval. Dr. Saranchova is a recognized expert in clinical research and immunology, with a distinguished career that includes roles as Honorary Professor/Lecturer at the University of British Columbia's Faculty of Medicine and Research Fellow at the Michael Smith Laboratories and Vancouver Prostate Center. Her expertise in biomarker discovery, clinical research, and immunotherapy development will be a key asset as Voyageur accelerates its scientific initiatives. #proactiveinvestors #voyageurpharmaceuticalsltd #tsxv #vm #vyyrf #ctscan #xray #BrentWillis, #RainCage, #Nanoscience, #MRI, #CTScan, #MedicalBreakthrough, #Fullerenes, #Vanadium, #Gadolinium, #Bismuth, #Iodine, #Radiology, #MedicalInnovation, #DrugDevelopment, #Healthcare, #ScientificBreakthrough, #Nanotechnology, #MedicalResearch, #Pharmaceuticals #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

CeADAR, Ireland's Centre for AI, is playing a leading role in the development of a new diagnostics system for the detection and monitoring of Alzheimer's Disease (AD). The €6m 2D-BioPAD project brings together 11 public and private institutions from across Europe with the aim of developing a point-of-care (PoC) diagnostics system capable of detecting the early signs of AD in a way that's faster, cheaper, more reliable, and less invasive than existing tools and procedures. Researchers aim to leverage previous studies by project partners into the unique properties of graphene, a material consisting of a single layer of atoms which is stronger than most steels and has more thermal and electrical conductivity than copper. Researchers hope that a graphene-based PoC diagnostics system will combine nano and DNA technologies to analyse patients' blood samples and identify and quantify up to five biomarkers for AD. CeADAR is leading the training and optimisation of the AI models to be used in the identification of biomarkers and the implementation of the system overall. An ageing population, rising life expectancy, and a lack of available treatments increased incidence and mortality due to AD by almost 150% between 2000 and 2019. It is expected that almost 19 million people across Europe will suffer from the disease by 2050. The increase in AD cases is already having serious implications for public healthcare systems around the world. It is estimated that the treatment of AD patients cost the US healthcare system more than $355bn in 2021 alone, while the labour from unpaid caregiving was estimated to be worth around $257bn. Researchers believe that early and accurate detection of AD will lead to better outcomes for patients who will benefit from more effective and less costly treatments, leading to a lower emotional burden and better quality of life for themselves and their families. It is also hoped that the system will make cutting-edge drug treatments available to the wider public. Currently, drug trials require participants be assessed according to their risk for AD, a costly process which is often inaccessible for the average person. 2D-BioPAD began in October 2023 and is expected to run until September 2027. The system and its impact will be assessed during two clinical trials in three centres in Finland, Greece and Germany. The first trial will focus on benchmarking and technical validation through several use cases. The larger second trial will involve up to 300 AD patients in real-life clinical settings. Head of Innovation & Development at CeADAR Ricardo Simon Carbajo says: "CeADAR is delighted to play such an important role in the development of a ground-breaking digital diagnostics system for the early detection and monitoring of AD. This tragic disease is afflicting more and more people globally each year. The 2D-BioPAD project represents an opportunity to utilise AI in a way that will make a significant difference to the lives of people with AD and their loved-ones. We're excited to be part of that." The project is being led by the Palacky University in Czech Republic. Greek contributors include Q-Plan International Advisers PC (Q-Plan), Aristotle University of Thessaloniki (AUTH), and Greek Association of Alzheimer's Disease and Related Disorders (GAADRD). Other project partners include Catalan Institute of Nanoscience and Nanotechnology in Spain (ICN2), Grapheal SAS in France, University of Eastern Finland and ENVIA APS in Denmark, and CeADAR, Ireland's Centre for AI.

In this episode, titled "Honoring Innovation: A Norwegian Tribute to Kavli Prize Winner Dr. Robert Langer, Sc.D.—A Mentor to Our Founder (DJ Ferguson)," we present a Norwegian-language interview with Dr. Langer, celebrating his recent achievement as a co-recipient of the Kavli Prize for Nanoscience, along with other scientists. -- Note: The views of this podcast represent those of my guest(s) and I. Note: Purpose of these episodes- not at all, for advice or medical suggestions. These are aimed to provide support for peer pharmacists in training in educational and intellectually stimulating ways. Again, these are not at all for medical advice, or for medical suggestions. Please see your local state and board-certified physician, PA or NP, and pharmacist for medical advice and suggestions.

Voyageur Pharmaceuticals CEO Brent Willis joined Steve Darling from Proactive to announce that the company and Rain Cage Carbon are advancing their collaboration following the first commercial creation of a V@C60 endohedral fullerene or Vanadium atom inside a C60 molecule. Rain Cage is now embarking on the next phase of radiology drug development using their cutting-edge technology. Willis told Proactive that Rain Cage will begin working to create on a commercial scale, the encapsulation of gadolinium, bismuth, and iodine within endohedral fullerenes. This pioneering work, set to begin later this month, aims to develop a process to create Gd@C60, Bi@C60, and I@C60 endohedral fullerenes, targeting the development of highly advanced radiology contrast agents for Magnetic Resonance Imaging (MRI) and CT scans. These novel compounds, known for their rarity and complex synthesis, hold the promise of transforming medical imaging by significantly enhancing the precision and clarity of radiological scans. Endohedral fullerenes are a class of fullerenes that enclose an additional atom, ion, or cluster within their inner sphere, exhibiting superior physical and electronic characteristics compared to regular fullerenes. In the context of radiology drugs, endohedral metallofullerenes offer distinct advantages through exceptional stability and bioavailability, an amplified signal that leads to better image clarity and resolution, targeted delivery, and reduced toxicity. These properties have garnered interest in applications such as MRI contrast agents #proactiveinvestors #voyageurpharmaceuticalsltd #tsxv #vm #vyyrf #ctscan #xray #BrentWillis, #RainCage, #Nanoscience, #MRI, #CTScan, #MedicalBreakthrough, #Fullerenes, #Vanadium, #Gadolinium, #Bismuth, #Iodine, #Radiology, #MedicalInnovation, #DrugDevelopment, #Healthcare, #ScientificBreakthrough, #Nanotechnology, #MedicalResearch, #Pharmaceuticals #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Maha Said is a post-doctoral researcher on the ERC-funded NanoBubbles project which asks the questions how, when, and why does science fail to correct itself. Originally trained in molecular and cellular biology and working close to science and technology studies especially science integrity, she is currently working in 2 sub-projects, the first being post publication peer review in which articles on the topic of interest are critically analyzed and publicly commented on Pubpeer, and second is the reproducibility project in which research articles that describe the use of nanoparticles for intracellular sensing are examined. On this podcast episode, Jo and Maha engage in a conversation focused on research integrity within the field of nanoparticles. Maha shares her journey into this area, driven by experiences of encountering integrity issues during her PhD research, particularly with antibodies. They discuss the challenges of peer review, replicability, and reproducibility, highlighting Maha's current work on post-publication peer review and replicability initiatives within nanoparticle research, specifically intracellular sensing. They also touch on the complexity of defining and implementing registered reports as a tool for ensuring transparency and accountability in research. Throughout their discussion, they emphasize the importance of critical analysis, collaboration across disciplines, and adaptation to changes in scientific processes. Find more podcast episodes here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://access2perspectives.pubpub.org/podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Host:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Dr Jo Havemann⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ORCID iD ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠0000-0002-6157-1494 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Editing: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Ebuka Ezeike⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Music:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Alex Lustig⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, produced by⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Kitty Kat ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ License:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Attribution 4.0 International (CC BY 4.0)   ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ At Access 2 Perspectives, we guide you in your complete research workflow toward state-of-the-art research practices and in full compliance with funding and publishing requirements. Leverage your research projects to higher efficiency and increased collaboration opportunities while fostering your explorative spirit and joy. Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://access2perspectives.pubpub.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ --- Send in a voice message: https://podcasters.spotify.com/pod/show/access2perspectives/message

In this enlightening episode of Research Renaissance, we journey into the future of brain science with Dr. Amy Bernard, the Director of Life Science at the Kavli Foundation. Together, we explore the intersections of bioscience and technology, academia, and philanthropy, unraveling how these domains are shaping groundbreaking advancements in understanding and treating neurological diseases.Key Highlights:Dr. Amy Bernard's Background and Role: Dr. Bernard shares her extensive experience in research, innovation, and philanthropy. As the head of strategy and programs for neuroscience and nanoscience divisions at the Kavli Foundation, she plays a pivotal role in pushing the boundaries of scientific understanding and treatment of neurological disorders.Intersecting Worlds of Nanoscience and Neuroscience: Dr. Bernard discusses her fascination with the microscopic and submicroscopic realms of biophysics and genetics, and how these fields contribute to our understanding of brain function and development of treatments for neurological disorders.The Significance of Open Science: The conversation delves into the importance of open science and data sharing in advancing research and creating accessible tools for the scientific community. Dr. Bernard highlights her experiences at the Allen Institute in promoting open science through web portals and databases.Exploring Neurobiology in Changing Ecosystems: Dr. Bernard expresses excitement about new research areas, particularly how climate change and environmental factors impact brain health. This reflects a broader interest in understanding the resilience and adaptability of the brain in response to external stressors.Advice for Early Career Researchers: Emphasizing the importance of passion, networking, and clear communication, Dr. Bernard offers advice to emerging scientists on navigating the challenges and opportunities in research and philanthropy.The Future of Brain Science and Philanthropy: The episode concludes with reflections on the potential of collaborative efforts in science philanthropy to address critical questions in brain science and beyond, underscoring the shared goal of advancing human knowledge and well-being.For more information about the Kavli Foundation and opportunities for collaboration or funding, visit kavlifoundation.org.Email Dr. Amy Bernard with ideas, questions, or feedback at science@kavlifoundation.org.To stay updated with the latest episodes and to learn more about the work of the Karen Toffler Charitable Trust in advancing brain science, subscribe to Research Renaissance and visit our website at tofflertrust.org. Feel free to reach out with thoughts, suggestions, or inquiries about getting involved in supporting brain science research.To learn more about the breakthroughs discussed in this episode and to support ongoing research, visit our website at tofflertrust.org. Technical Podcast Support by Jon Keur at Wayfare Recording Co.

Professor Mike Curry of the North Carolina Agricultural & Technological State University (NCAT) is a scientist, inventor, mentor, and advocate with a passion for bringing attention to the great research that happens at Historically Black Colleges & Universities (HBCUs). In this episode we share an interview between Dr. Curry and Dr. Bob Hamers, Director of the NSF Center for Sustainable Nanotechnology, discussing Dr. Curry's nanocellulose research and the process of bringing HBCUs and Primarily White Institutions (PWIs) together for meaningful collaboration.image shows Mike Curry (above) and Bob Hamers (below) during their Zoom call to record this interviewWant more podcast episodes? You can find them all on our podcast page, or you can subscribe through Apple Podcasts or Overcast, or listen on NSF's Science Zone Radio.ABOUT THIS EPISODERelated links:Mike Curry:  CSN profile, LinkedInBob Hamers:  CSN profile, Lab websiteAccounts of Chemical Research: Special Issue on Advancing Research at HBCUsNCAT Joint School of Nanoscience and Nanoengineering,Podcast episode 12: Making Sustainable Nanoparticles from Plants with Mike CurryPodcast episode 7: What Do Glaciers Have to Do with Nanoscience? with Bob HamersCSN & Curry group alum Dr. Donald WhiteBinghamton University Emerging Science & Technology SummitNSF Ideas Lab: Advancing Research Capacity at HBCUs through Exploration and Innovation (ARC-HBCU)Recent patent: High-throughput synthesis of metallic nanoparticlesThe NSF Center for Sustainable NanotechnologyInterviewee: Mike CurryInterviewer: Bob HamersProducer/Host: Miriam KrauseMusic: PC III and Dexter BritainThis material is based upon work supported by the National Science Foundation under the Center for Sustainable Nanotechnology, grant number CHE-2001611. Any opinions, findings, and conclusions or recommendations expressed on this podcast are those of the participants and do not necessarily reflect the views of the National Science Foundation or the participating institutions.

Ever heard the terms "Nanoscience or Nanoengineering"? Find out more, plus how middle and high school female students can take part in a great experience designed for girls and parents to learn from women in STEM at all ages. During this episode of Talk City Greensboro, we are joined by longtime educator Laura Tew with the Joint School of Nanoscience and Nanoengineering.

The DAC-Cast hosts are back with 60DAC keynote speaker and IBM Fellow, Head of Science & Technology and Lead of IBM Research Quantum Europe at IBM Research, Heike Riel. Listen today to hear her story, where she is now - leading the research agenda of the Science & Technology department aiming to create scientific and technological breakthroughs in Quantum Computing, Physics of Artificial Intelligence, Nanoscience and Nanotechnology, Precision Diagnostics and Smart System Integration.

Matt Martin, Managing Director of Oxford Instruments Nanoscience is interviewed by Yuval Boger. Matt discusses his company's focus on dilution refrigerators for quantum computing, the differentiation between different refrigerators, modular designs, and scalability considerations. We also cover service, maintenance aspects, recent developments, and much more.

Green Chemistry is incredibly important topic for more sustainable research practices in all kinds of industries, including and not limited to, such as, oil & gas, pharmaceuticals, beauty producats, fragrance industry. Check out the full episode - ⁠⁠Nanoscience revolusionising Green Chemistry? Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠RealScientists Nano⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on Twitter to meet a new materials/nano scientist every week. Join our ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠mailing list⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Subscribe to our channel and follow on socials https://www.youtube.com/@the_ sciencetalk LINKEDIN - @The Science Talk https://www.linkedin.com/company/the-science-talk/ TWITTER - @The_ScienceTalk @RealSci_Nano https://twitter.com/the_ScienceTalk https://twitter.com/RealSci_Nano INSTAGRAM - @TheScience_Talk https://www.instagram.com/thescience_talk/ BLUESKY - @TheScienceTalk https://bsky.app/profile/thesciencetalk.bsky.social MASTODON - @RealSci_Nano https://mastodon.social/@RealSci_Nano --- Send in a voice message: https://podcasters.spotify.com/pod/show/under-microscope/message

The future is getting smaller, but like in the good way. Tom and Neil Hoover talk to Dennis LaJeunesse, a nano scientist at the Joint School of Nanoscience and Nanoengineering. There seems to be unlimited potential with nano engineering, curing cancer, lab grown meats, surgery, mapping the brain, limb regeneration, renewable energy, and saving the planet! No pressure though. Also find out what else you're eating in your bananas! #podcast #science #technology #tech #scientist #research #nanotech #microscope #exponential

Pranoti sits down with Steve, Postdoc researcher at University of Victoria (Canada), and talks about nano hockey sticks to win over diseases! Steve's socials ⁠Twitter⁠ ⁠Instagram⁠ ⁠LinkedIn⁠ Follow ⁠RealScientists Nano⁠ on Twitter to meet a new materials/nano scientist every week. Join our ⁠mailing list⁠ Be our ⁠Patron⁠ ⁠ABSTRACT SUBMISSION⁠ for the 6th NANOscientific Forum Europe 2023 (#nsfe2023) is open!    Join this European SPM Meeting and be a part of exciting talks from the nanoresearch field, practical hands-on-sessions on High Resolution AFM Imaging, Scanning ElectroChemical Cell Microscopy (SECCM), Kelvin Probe Force Microscopy (KPFM), AFM Automation for Advanced NanoResearch; not to mention a thrilling social program in Barcelona's flair! --- Send in a voice message: https://podcasters.spotify.com/pod/show/under-microscope/message

“Il vero modo per riuscire ad affrontare correttamente la transizione energetica è quello di spingere il sistema economico e il sistema della ricerca a trovare delle soluzioni che vadano oltre la combustione interna”Il ricercatore IIT Fabrizio Pirri è ospite dell'ottavo episodio di Voices From The Labs. Coordinatore del Center for Sustainable Future Technologies dell'Istituto Italiano di Tecnologia a Torino, si occupa di sviluppare tecnologie sostenibili per la transizione energetica. Tra i diversi argomenti, abbiamo parlato dei 4 assi seguiti dal centro di Torino (CO2, idrogeno, stoccaggio di energia elettrica e produzione di energia da microrganismi), delle attività di ricerca legate al PNRR, che porteranno alla costruzione di un polo legato alle tecnologie della transizione energetica e allo sviluppo di prototipi, e del ruolo dei finanziamenti privati nel facilitare la transizione tra prototipo e prodotto industriale.Per quanto riguarda le news parleremo dell'accordo di ricerca firmato tra IIT e Terna, la società che gestisce la trasmissione elettrica nazionale, del primo prototipo al mondo di batteria ricaricabile e commestibile, realizzata dal gruppo di ricerca Printed and Molecular Electronics di Mario Caironi al Center for Nano Science and Technology di IIT a Milano. Passeremo poi al robot biodegradabile a forma di seme sviluppato dal gruppo di ricerca Bioinspired Soft Robotics di Barbara Mazzolai nell'ambito del progetto europeo I-Seed e, infine, alla competizione di divulgazione scientifica internazionale FameLab, che ha visto vincitrici le ricercatrici IIT Despoina Kossyvaki e Irene Guerriero per la selezione locale genovese.Ai microfoni nell'episodio “Le tecnologie per la sostenibilità tra PNRR e transizione energetica” Giuliano Greco e Valeria delle Cave, alla parte tecnica Gioele Lecquio.

Chad Mirkin is the Director of the International Institute for Nanotechnology and the George B. Rathmann Prof. of Chemistry, Prof. of Chemical and Biological Engineering, Prof. of Biomedical Engineering, Prof. of Materials Science & Engineering, and Prof. of Medicine at Northwestern University.He is a chemist and a world-renowned nanoscience expert, who is known for his discovery and development of spherical nucleic acids (SNAs) and SNA-based biodetection and therapeutic schemes, the invention of Dip-Pen Nanolithography (DPN) and related cantilever-free nanopatterning methodologies, On-Wire Lithography (OWL), Co-Axial Lithography (COAL), and contributions to supramolecular chemistry and nanoparticle synthesis. He is the author of over 850 manuscripts and over 1,200 patent applications worldwide (over 400 issued), and the founder of multiple companies, including Nanosphere, AuraSense, TERA-print, Azul 3D, MattIQ, and Flashpoint Therapeutics.Mirkin has been recognized for his accomplishments with over 250 national and international awards. These include the King Faisal Prize in Science, the Faraday Medal, UNESCO-Equatorial Guinea International Prize for Research in Life Sciences, Kabiller Prize in Nanoscience and Nanomedicine, the SCI Perkin Medal, Friendship Award, Nano Research Award, AAAS Philip Hauge Abelson Award, Richards Award and Medal, Harrison Howe Award, the Remsen Award, Ralph N. Adams Award, the Dickson Prize in Science, the RUSNANOPRIZE, the Nichols Medal, the 2016 Dan David Prize, the inaugural NAS Sackler Prize in Convergence Research, the RSC Centenary Prize, the Friends of the National Library of Medicine Distinguished Medical Science Award, the 2014 National Security Science and Engineering Fellowship (NSSEFF) Award, the 2014 Thomson Reuters Highly Cited Researcher (2002-2012), the ACS Nano Lectureship Award for the Americas, the Vittorio deNora Award (The Electrochemical Society), the Linus Pauling Medal, the Thomson Reuters “Nobel-Class” Citation Laureate, RSC's “Chemistry World” Entrepreneur of the Year Award, a Honorary Membership in the Materials Research Society of India, the Walston Chubb Award for Innovation, an Honorary Degree from Nanyang Technological Univ. Singapore, recognition as the Lee Kuan Yew Distinguished Visitor to Singapore, an Honorary Professorship from Hunan Univ. China, the ACS Award for Creative Invention, the Herman S. Bloch Award for Scientific Excellence in Industry, an Einstein Professorship of the Chinese Academy of Sciences, the Edward Mack Jr. Memorial Award, the $500,000 Lemelson-MIT Prize, the Havinga Medal, the Gustavus John Esselen Award, the Biomedical Eng. Society's Distinguished Achievement Award, a DoD NSSEFF Award, the Pittsburgh Analytical Chemistry Award, the ACS Inorganic Nanoscience Award, the iCON Innovator of the Year Award, a NIH Director's Pioneer Award, the Collegiate Inventors Award, an Honorary Doctorate Degree from Dickinson College, the Pennsylvania State Univ. Outstanding Science Alumni Award, the ACS Nobel Laureate Signature Award for Graduate Education in Chemistry, a Dickinson College Metzger-Conway Fellowship, the 2003 Raymond and Beverly Sackler Prize in the Physical Sciences, the Feynman Prize in Nanotechnology, the Leo Hendrick Baekeland Award, Crain's Chicago Business “40 under 40 Award,” the Discover 2000 Award for Technological Innovation, I-Street Magazine's Top 5 List for Leading Academics in Technology, the Materials Research Society Young Investigator Award, the ACS Award in Pure Chemistry, the PLU Fresenius Award, the Harvard University E. Bright Wilson Prize, the BF Goodrich Collegiate Inventors Award, the Camille Dreyfus Teacher-Scholar Award, the Alfred P. Sloan Foundation Award, the DuPont Young Professor Award, the NSF Young Investigator Award, the Naval Young Investigator Award, the Beckman Young Investigator Award, and the Camille and Henry Dreyfus Foundation New Faculty Award.Mirkin served as a Member of the President's Council of Advisors on Science & Technology (Obama Administration) for eight years, and he is one of very few scientists to be elected to all three US National Academies (Medicine, Science, and Engineering), and in addition, he is a Member of the American Academy of Arts and Sciences, and a Fellow of the National Academy of Inventors, the American Chemical Society, the American Institute for Medical and Biological Engineering, the Materials Research Society, and others. Mirkin has served on the Editorial Advisory Boards of over 30 scholarly journals, including JACS, Acc. Chem. Res., Angew. Chem., Adv. Mater., Biomacromolecules, Macromolecular Bioscience, SENSORS, Encyclopedia of Nanoscience and Nanotechnology, Chem. Eur. J., Chemistry & Biology, Nanotechnology Law & Business, The Scientist, J. Mater. Chem., J. Cluster Sci., and Plasmonics. He is the founding editor of the journal Small, one of the premier international nanotechnology journals, and he has co-edited multiple bestselling books. Mirkin holds a B.S. degree from Dickinson College (1986, elected into Phi Beta Kappa) and a Ph.D. degree in Chemistry from Penn. State Univ. (1989). He was an NSF Postdoctoral Fellow at MIT prior to becoming a professor at Northwestern Univ. in 1991.Alix Ventures, by way of BIOS Community, is providing this content for general information purposes only. Reference to any specific product or entity does not constitute an endorsement nor recommendation by Alix Ventures, BIOS Community, or its affiliates. The views & opinions expressed by guests are their own & their appearance on the program does not imply an endorsement of them nor any entity they represent. Views & opinions expressed by Alix Ventures employees are those of the employees & do not necessarily reflect the view of Alix Ventures, BIOS Community, affiliates, nor its content sponsors.Thank you for listening!BIOS (@BIOS_Community) unites a community of Life Science innovators dedicated to driving patient impact. Alix Ventures (@AlixVentures) is a San Francisco based venture capital firm supporting early stage Life Science startups engineering biology to create radical advances in human health.Music: Danger Storm by Kevin MacLeod (link & license)

Pranoti sits down with Julio, Postdoc researcher at EPFL (Switzerland), and talks about green chemistry, his fresh postdoc start at EPFL, little prince analogy and how all chemistry should be green chemistry. Find Julio on different socials - ⁠Twitter⁠ ⁠Instagram⁠ ⁠LinkedIn⁠ ⁠Navigate Twitter as a Scientist ⁠⁠- Mar 22 - ⁠access recording Follow ⁠RealScientists Nano⁠ on Twitter to meet a new materials/nano scientist every week. Join our ⁠mailing list⁠ Be our ⁠Patron⁠ ⁠ABSTRACT SUBMISSION⁠ for the 6th NANOscientific Forum Europe 2023 (#nsfe2023) is open!    Join this European SPM Meeting and be a part of exciting talks from the nanoresearch field, practical hands-on-sessions on High Resolution AFM Imaging, Scanning ElectroChemical Cell Microscopy (SECCM), Kelvin Probe Force Microscopy (KPFM), AFM Automation for Advanced NanoResearch; not to mention a thrilling social program in Barcelona's flair! --- Send in a voice message: https://podcasters.spotify.com/pod/show/under-microscope/message

Dennis LaJeunesse has been researching nano science and technology for decades. So much about how our world works can be answered looking down to the nanometer. As with any field of science, more questions are asked than answered...that's job security baby!! Dennis is working on a fabric like material that could become stronger when it's wet and silly putty knees! Also, forget your external hard rive! You could be storing stuff in DNA! That's a lot of episodes of The Creative Businessmen! #science #scientist #scienceexperiment #sciencefacts #nano #technology #tech #research #phd

David works at NanoScience Instruments. Hear how David went from working with computers to working with advanced nanotechnology characterization and fabrication instruments. David talks about how important completing a 1-year certificate from Rio Salado Community College was to his professional journey. The Talking Technicians podcast is produced by MNT-EC, the Micro Nano Technology Education Center, through financial support from the National Science Foundation's Advanced Technological Education grant program.Opinions expressed on this podcast do not necessarily represent those of the National Science Foundation.Join the conversation. If you are a working technician or know someone who is, reach out to us at info@talkingtechnicians.org.Links from the show:The Micro Nano Technology Education Center (MNT-EC): https://micronanoeducation.org/Nanoscience Instruments: https://www.nanoscience.com/Rio Salado College Certificate of Completion in Nanotechnology: https://www.riosalado.edu/degrees-certificates/applied-technology/nanotechnology-and-manufacturing-5276-cclEpisode Web Page: https://micronanoeducation.org/students-parents/talking-technicians-podcast/

Plus here's a sneak peak into UNLEASH 2023! Welcome back SDG Talkers!! Thanks for joining us for another episode of highlighting change makers and their inspirational work towards the United Nations Sustainable Development Goals (SDGs)! IN THIS EPISODE: Why unite youth to unleash change towards the SDGs? The history & future of the UNLEASH program A reflection on the 1st regional lab in Greenland Hear from the Chairman of the Board of UNLEASH Flemming Besenbacher! Flemming is also the Founding Director of iNANO at Aarhus University where he was Professor of Nanoscience and Physics for many years. He has ample experience researching Nanoscience, nanotechnology, nanocatalysis, scanning tunnelling microscopy, atomic force microscopy, and is committed to bringing the world together to create a better tomorrow. Let's get SDG Talking!! Got a good story or want to collaborate? Send us an email at sdgtalkspodcast@gmail.com and we will get back to you as soon as we can! And don't forget to check out our Virtual Roundtables on our website! Instagram | Facebook | Twitter | LinkedIn

Arriva il primo sensore autoalimentato e commestibile, che potrà essere utilizzato per rilevare lo scongelamento irregolare degli alimenti. Il nuovo dispositivo è stato descritto in un articolo pubblicato sulla rivista ACS Sensors da un gruppo di ricercatori del Center for Nano Science end Technology dell'Istituto Italiano di Tecnologia. Il sensore è composto di cera d'api, con l'aggiunta di un po' di sale e una punta di succo di cavolo rosso. Quando avviene uno scongelamento, i sali generano una piccola corrente elettrica che modifica il colore del succo di cavolo, e il gioco è fatto. Ospite: Marco Caironi, Responsabile della linea di ricerca Printed and Molecular Electronics dell'IIT

Do you know that there is an international science image competition that combines nanoscience and art? This is called NanoArtography. Every year of the competition has garnered over 100 submissions, and researchers from over 20 different countries submitted images of their research to illustrate what they are studying and showcase its beauty.   In today's episode, we welcome Dr. Babak Anasori, the Editor in Chief for the new Graphene and 2D Materials journal at Springer Nature Group and an Assistant Professor at the Purdue University School of Engineering. With him we discuss:  

Jacob Sagiv is a chemist who studies properties of self-assembled monolayers. This year, he shared The Kavli Prize in Nanoscience for his research.

Jacob Sagiv is a chemist who studies properties of self-assembled monolayers. This year, he shared The Kavli Prize in Nanoscience for his research.

Please join me for a  scientific discussion with Dr. Xiaobo Mao, Associate Professor with Johns Hopkins School of Medicine, around future Parkinson's related therapies and the cure for Parkinson'sDr. Mao is currently an Associate Professor with Johns Hopkins School of Medicine where he has extensive work in the hospital & health care industry. Dr. Mao gained his PhD at the National Center for Nanoscience and Technology, China, Chinese Academy of Sciences in 2010 and conducted his post doctoral training at Johns Hopkins University School of Medicine in 2016 where his research focuses on alpha-synuclein proteins and how their misfolding and spread can lead to Parkinson's Disease.  This discovery holds potential promise for future Parkinson's related therapies.His discoveries are one of 40 key discoveries in 200 years of Parkinson's Disease research. 

We hear from three eminent researchers who take us into the nano universe where they study miniscule openings in the cells of our bodies…passageways called nuclear pore complexes. These complexes are incredibly smart collections of proteins that direct traffic into and out of the nuclei of our cells…where our DNA is located.   Joining us are Cees Dekker, professor of molecular biophysics at Delft University of Technology in the Netherlands and director of the Kavli Institute of Nanoscience; Michael Rout, professor of biochemistry and biophysics at Rockefeller University in New York; and Anton Zilman, professor of biological physics at the University of Toronto.  They appeared during a Telluride Science “Town Talk” at the Transfer Warehouse in Telluride, a session moderated by award-winning broadcast journalists Judy Muller and George Lewis. 

Dr. Presser is an Aussie on a deeply spiritual journey, who's also into the joy and fun of life. He has a PhD in Materials Engineering and was involved in the IT industry for many years before beginning his spiritual journey in the early 90's. He distributes two product ranges globally that have a key role in this time of change. "I have come to understand that my life is deeply connected to this time pf planetary change we are living through. I believe we live in a special time on the planet, when our beautiful planet and all who remain upon it will be set free. May it be so." - Dr. Richard Presser XOXOXOXOXOXOXOXOXOXOXOXOXOXOXOXOXOXOXOXOXOXOXOXOXOXOXOX Have you checked out https://pleazeme.com? It is a social media platform where adults can be adults. We created the 7 Worlds of PleazeMe so that every person would have a place to privately explore their sexuality with like-minded people. We believe in love, sexuality, and the power of inclusion. People of all shapes and sizes, colors and ethnicities, genders and sexualities are valuable and deserve to feel included. Everyone should have a safe place they can go to connect, discover and express themselves without fear of being judged, censored or discriminated against.

In this episode, I sat down with my colleague, Prof. Tod A. Pascal, of the Department of NanoEngineering and Chemical Engineering at UC San Diego. Tod developed an interest in computational materials science at a young age while growing up on the island of Grenada in the Caribbean. During his schooling, he spent significant time in Houston, New York, Philadelphia, Pasadena, South Korea, Japan, and Berkeley, before starting his lab at UCSD. In our wide-ranging discussion, we talk about how he became a computational materials scientist, what it was like to do research in such varied environments, and how computation can be used to expand access to technical education in underserved communities.

About Suman Das and DDM Systems: Founder of DDM Systems, a Silicon Valley venture backed digital manufacturing company. Entrepreneur in the commercialization of disruptive technologies for additive manufacturing. Chair Professor of Advanced Manufacturing Systems at Georgia Tech with broad expertise in advanced and additive manufacturing techniques. Thirty years of experience in research, design, development, and optimization of additive manufacturing techniques for polymers, high temperature metals, ceramics, and composites with applications in aerospace turbine engines, resorbable implants for tissue regeneration, precision investment casting ceramic molds, polymer nanocomposites, and solid oxide fuel cells. Expert in equipment and process design, and process control for additive manufacturing. Materials processing expertise involving various lasers and length scales as well as large-area laser microfabrication and nanofabrication, maskless photopolymerization, and maskless lithography. Specialties: Direct Digital Manufacturing, Additive Manufacturing, 3-D Printing, Direct Part Manufacturing, Nanoscience and Nanotechnology, Laser Microfabrication and Nanofabrication, Photopolymerization, Maskless Lithography, Rapid Prototyping, Design and Manufacturing, Lasers, Laser Materials Processing, Biomaterials, Biomedical Implants, Tissue Engineering, Aerospace materials and structures, Superalloys, Fuel Cells. Additive Manufacturing of Ceramics, Nickel-base Superalloys, Polymers and Polymer Nanocomposites. DDM Systems is an Atlanta-based additive manufacturing and 3D printing startup. The company was founded in 2012 by Suman Das and John Halloran to rapidly commercialize LAMP™and SLE™, two disruptive manufacturing technologies with immediate applications in the aerospace and industrial gas turbines sectors. Large Area Maskless Photopolymerization (LAMP™) is a breakthrough additive technology for the tool-less, on-demand and affordable direct digital manufacturing (DDM) of ceramic cores and integral-cored shell molds for investment casting of high-precision, high-performance turbine engine hot-section components such as airfoils. LAMP produced ceramic cores are fully compatible with current investment casting foundry practices. Scanning Laser Epitaxy (SLE™) builds upon over two decades of metal powder bed-based laser additive manufacturing experience and achieves a breakthrough in manufacture and repair of high-value turbine engine hot-section components made of non-weldable superalloys. SLE achieves controlled epitaxial deposition of equiaxed (EQ), directionally-solidified (DS) and single-crystal (SX) materials to produce fully dense, crack-free structures. This capability surpasses existing metal additive techniques. In response to the rapidly growing demand for both technologies, DDM Systems will deliver commercial systems in 2015.

Carbon Queen: The Remarkable Life of Nanoscience Pioneer Mildred Dresselhaus (MIT Press, 2022) follows Mildred Dresselhaus (or Millie, as everyone calls her) from her childhood in New York City to her final years in Cambridge. It focuses on her scientific achievements, but also rightfully presents her as a multi-hyphenate: being a resilient student, an adaptive researcher, a professor, an administrator, an advocate, a fundraiser, a patent owner, a book author. The accolades are plentiful and her involvement in science seemingly boundless. Maia Weinstock masterfully blends anecdotes and scientific explanations into the life story of a truly phenomenal scientist. In this episode of the podcast, we discuss Millie's multifaceted career, as well as the process of putting the book together, and Maia's history course on women in science. Ana Georgescu studied astrophysics and physics at Harvard University and is now a science consultant and writer based in New York City. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Carbon Queen: The Remarkable Life of Nanoscience Pioneer Mildred Dresselhaus (MIT Press, 2022) follows Mildred Dresselhaus (or Millie, as everyone calls her) from her childhood in New York City to her final years in Cambridge. It focuses on her scientific achievements, but also rightfully presents her as a multi-hyphenate: being a resilient student, an adaptive researcher, a professor, an administrator, an advocate, a fundraiser, a patent owner, a book author. The accolades are plentiful and her involvement in science seemingly boundless. Maia Weinstock masterfully blends anecdotes and scientific explanations into the life story of a truly phenomenal scientist. In this episode of the podcast, we discuss Millie's multifaceted career, as well as the process of putting the book together, and Maia's history course on women in science. Ana Georgescu studied astrophysics and physics at Harvard University and is now a science consultant and writer based in New York City. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/history

Carbon Queen: The Remarkable Life of Nanoscience Pioneer Mildred Dresselhaus (MIT Press, 2022) follows Mildred Dresselhaus (or Millie, as everyone calls her) from her childhood in New York City to her final years in Cambridge. It focuses on her scientific achievements, but also rightfully presents her as a multi-hyphenate: being a resilient student, an adaptive researcher, a professor, an administrator, an advocate, a fundraiser, a patent owner, a book author. The accolades are plentiful and her involvement in science seemingly boundless. Maia Weinstock masterfully blends anecdotes and scientific explanations into the life story of a truly phenomenal scientist. In this episode of the podcast, we discuss Millie's multifaceted career, as well as the process of putting the book together, and Maia's history course on women in science. Ana Georgescu studied astrophysics and physics at Harvard University and is now a science consultant and writer based in New York City. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/biography

Carbon Queen: The Remarkable Life of Nanoscience Pioneer Mildred Dresselhaus (MIT Press, 2022) follows Mildred Dresselhaus (or Millie, as everyone calls her) from her childhood in New York City to her final years in Cambridge. It focuses on her scientific achievements, but also rightfully presents her as a multi-hyphenate: being a resilient student, an adaptive researcher, a professor, an administrator, an advocate, a fundraiser, a patent owner, a book author. The accolades are plentiful and her involvement in science seemingly boundless. Maia Weinstock masterfully blends anecdotes and scientific explanations into the life story of a truly phenomenal scientist. In this episode of the podcast, we discuss Millie's multifaceted career, as well as the process of putting the book together, and Maia's history course on women in science. Ana Georgescu studied astrophysics and physics at Harvard University and is now a science consultant and writer based in New York City. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science

Carbon Queen: The Remarkable Life of Nanoscience Pioneer Mildred Dresselhaus (MIT Press, 2022) follows Mildred Dresselhaus (or Millie, as everyone calls her) from her childhood in New York City to her final years in Cambridge. It focuses on her scientific achievements, but also rightfully presents her as a multi-hyphenate: being a resilient student, an adaptive researcher, a professor, an administrator, an advocate, a fundraiser, a patent owner, a book author. The accolades are plentiful and her involvement in science seemingly boundless. Maia Weinstock masterfully blends anecdotes and scientific explanations into the life story of a truly phenomenal scientist. In this episode of the podcast, we discuss Millie's multifaceted career, as well as the process of putting the book together, and Maia's history course on women in science. Ana Georgescu studied astrophysics and physics at Harvard University and is now a science consultant and writer based in New York City. Learn more about your ad choices. Visit megaphone.fm/adchoices

Carbon Queen: The Remarkable Life of Nanoscience Pioneer Mildred Dresselhaus (MIT Press, 2022) follows Mildred Dresselhaus (or Millie, as everyone calls her) from her childhood in New York City to her final years in Cambridge. It focuses on her scientific achievements, but also rightfully presents her as a multi-hyphenate: being a resilient student, an adaptive researcher, a professor, an administrator, an advocate, a fundraiser, a patent owner, a book author. The accolades are plentiful and her involvement in science seemingly boundless. Maia Weinstock masterfully blends anecdotes and scientific explanations into the life story of a truly phenomenal scientist. In this episode of the podcast, we discuss Millie's multifaceted career, as well as the process of putting the book together, and Maia's history course on women in science. Ana Georgescu studied astrophysics and physics at Harvard University and is now a science consultant and writer based in New York City. Learn more about your ad choices. Visit megaphone.fm/adchoices

Carbon Queen: The Remarkable Life of Nanoscience Pioneer Mildred Dresselhaus (MIT Press, 2022) follows Mildred Dresselhaus (or Millie, as everyone calls her) from her childhood in New York City to her final years in Cambridge. It focuses on her scientific achievements, but also rightfully presents her as a multi-hyphenate: being a resilient student, an adaptive researcher, a professor, an administrator, an advocate, a fundraiser, a patent owner, a book author. The accolades are plentiful and her involvement in science seemingly boundless. Maia Weinstock masterfully blends anecdotes and scientific explanations into the life story of a truly phenomenal scientist. In this episode of the podcast, we discuss Millie's multifaceted career, as well as the process of putting the book together, and Maia's history course on women in science. Ana Georgescu studied astrophysics and physics at Harvard University and is now a science consultant and writer based in New York City. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science-technology-and-society

Carbon Queen: The Remarkable Life of Nanoscience Pioneer Mildred Dresselhaus (MIT Press, 2022) follows Mildred Dresselhaus (or Millie, as everyone calls her) from her childhood in New York City to her final years in Cambridge. It focuses on her scientific achievements, but also rightfully presents her as a multi-hyphenate: being a resilient student, an adaptive researcher, a professor, an administrator, an advocate, a fundraiser, a patent owner, a book author. The accolades are plentiful and her involvement in science seemingly boundless. Maia Weinstock masterfully blends anecdotes and scientific explanations into the life story of a truly phenomenal scientist. In this episode of the podcast, we discuss Millie's multifaceted career, as well as the process of putting the book together, and Maia's history course on women in science. Ana Georgescu studied astrophysics and physics at Harvard University and is now a science consultant and writer based in New York City. Learn more about your ad choices. Visit megaphone.fm/adchoices

During this time of lockdown, the centre for quantum software and information (QSI) at the University of Technology Sydney has launched an online seminar series. With talks once or twice a week from leading researchers in the field, meQuanics is supporting this series by mirroring the audio from each talk. I would encourage if you listen to this episode, to visit and subscribe to the UTS:QSI YouTube page to see each of these talks with the associated slides to help it make more sense. https://youtu.be/Dg6Q_F9uI8s Silicon spin qubits gain traction for large-scale quantum computation and simulation. TITLE: A Scalable “Spins-Inside” Quantum Processor and Simulator SPEAKER: Prof Lieven Vandersypen AFFILIATION: QuTech, Kavli Institute of Nanoscience, Dept of Quantum Nanoscience, Delft University of Technology, Netherlands HOSTED BY: Dr JP (Juan Pablo) Dehollain, UTS Centre for Quantum Software and Information ABSTRACT: Excellent control of over physical 50 qubits has been achieved, but can we also realize 50 fault-tolerant qubits? Here quantum bits encoded in the spin state of individual electrons in silicon quantum dot arrays have emerged as a highly promising avenue. In this talk, I will present our vision of a large-scale spin-based quantum processor, and our ongoing work to realize this vision. I will also show how the same platform offers a powerful platform for analog quantum simulation of Fermi-Hubbard physics and quantum magnetism. RELATED ARTICLES: Physics Today 72(8), 38 (2019) npj Quantum Information 3, 34 (2017) Nature 555, 633 (2018) Science 359, 1123 (2018) Phys. Rev. X 9, 021011 (2019) Nature 579, 528 (2020) Nature 580, 355 (2020) OTHER LINKS: Vandersypen Lab: qutech.nl/vandersypen-lab/ Delft University of Technology: https://www.tudelft.nl/

In this episode of the “Stories from the NNI” podcast, Sherine Obare, the Dean of the Joint School of Nanoscience and Nanoengineering at the North Carolina Agricultural and Technical State University and the University of North Carolina at Greensboro, discusses her work developing sensors to detect environmental pollutants.   If you would like to learn more about nanotechnology, go to nano.gov or email us at info@nnco.nano.gov. Closed captioning is provided on our YouTube channel. For this episode, go to: https://youtu.be/QYwBrL0631M CREDITS Special thanks to:  Sherine ObareNorth Carolina Agricultural and Technical State University and University of North Carolina at Greensboro  Produced by:Andrew Pomeroy Music:  Inspirational Outlook by Scott Holmes  https://freemusicarchive.org/music/Sc...https://creativecommons.org/licenses/... Any opinions, findings, conclusions, or recommendations expressed in this podcast are those of the guest and do not necessarily reflect the views of the National Nanotechnology Coordination Office or United States Government. Additionally, mention of trade names or commercial products does not constitute endorsement or recommendation by any of the aforementioned parties. Any mention of commercial products, processes, or services cannot be construed as an endorsement or recommendation.

This episode features an interview with Dr. Roy Schwartzman. Dr. Roy Schwartzman is a Professor in the Department of Communication Studies at the University of North Carolina, Greensboro. He serves as a faculty affiliate with the Department of Peace and Conflict Studies; the Joint School of Nanoscience and Nanoengineering; and the Women's, Gender, and Sexuality Studies Program at UNCG. Author of more than 150 scholarly articles/chapters and 350 poetry publications, he has won more than 20 research awards and 60 literary awards. He is Principal Investigator of Cultivate Resilient Communities, the grant that established UNCG as the inaugural NCA Center for Communication, Community Collaboration, and Change.. He is the founding administrator of the Facebook mega-group Pandemic Pedagogy and has been named a Facebook Power Administrator. For more information on The Big Rhetorical Podcast visit thebigrhetoricalpodcast.weebly.com.

In this episode of Lab to Startup, I speak with Shannon Ciston and Branden Brough. Branden is the Deputy director of Molecular Foundry at the Lawrence Berkeley National Labs and Shannon is the Director of the User Program. We explore various resources that Molecular Foundry offers like: World-class scientists with expertise across a broad range of disciplines and state-of-the-art instrumentation. How to get accepted to the program Cost to users (mostly free) Intellectual property rights from using their support Examples of startups that benefited from the program Learn more about Molecular Foundry: foundry.lbl.gov

Gerd Binnig shared The Kavli Prize in Nanoscience in 2016 for inventing the atomic force microscope. What transformative impact has this invention had on nanoscience?

(0:55) - Using Nanoparticles To Detect Cancer In Pee: A team of MIT engineers have come up with a way to detect the presence of cancer and localize the region of origin by analyzing a patient's pee sample. The patient can either inhale or be injected with nanoparticles that'll exit the body via urine and a paper test - similar to over the counter pregnancy tests - can be used to determine if the patient has cancer. Additionally, if the patient does test positive, the nanoparticles can be coated with a radioactive tracer to show medical professionals the source of the growth via PET scans.(8:20) - Robotic Neck Brace: Head and neck cancer is the 7th most common type of cancer in the world and doctors typically surgically remove a patient's lymph nodes to examine how the cancer will spread; however, this approach results in severe neck and shoulder pain. This type of pain is difficult to characterize because current methods are either too timely to set up or they're simply inaccurate but that is exactly what a group of Columbia researchers hoped to address. Two professors have teamed up to create a robotic neck brace capable of recording a patient's full range of head/neck motion. The duo have proven that by recording data before and after the surgery will allow medical professionals to understand what areas have been affected and what specific types of physical therapy to prescribe. (13:55) - Quiet Landing Airplanes: If you live near an airport (like us) then you know how disturbing the sound of planes taking off and landing can be. Fortunately, a team of engineers at Texas A&M University have proposed a design modification to the slats on aircraft wings that could reduce the noise generated upon landing to that of the quietest planes. Their simulations have been promising so now they will be working on creating a scale model to test out and hopefully it works so The Next Byte crew can have an easier time living near the airport. --About the podcast:Every day, some of the most innovative universities, companies, and individual technology developers share their knowledge on Wevolver. To ensure we can also provide this knowledge for the growing group of podcast listeners, we started a collaboration with two young engineers, Daniel Scott Mitchell & Farbod Moghaddam who discuss the most interesting content in this podcast series. To learn more about this show, please visit the shows page. By following the page, you will get automatic updates by email when a new show is published.Be sure to give us a follow and review on Apple podcasts, Spotify, and most of your favorite podcast platforms!Take a few seconds to leave us a review. It really helps! https://apple.co/2RIsbZ2 if you do it and send us proof, we'll give you a shoutout on the show.

Take a few seconds to leave us a review. It really helps! https://apple.co/2RIsbZ2 if you do it and send us proof, we'll give you a shoutout on the show.(0:49) - Nanostructured Shields: MIT, CalTech, and ETH Zurich researchers have developed a new lightweight material capable of providing more stopping power than kevlar on a per mass basis. Furthermore, they were able to use the Buckingham-pi theorem - an analytical method used to measure how much material a meteor can excavate from a planet - to create a framework for assessing the impact absorption effectiveness of new nanostructured materials. (10:55) - Balloon Detection of Venus Earthquakes: Much of what we know about the inner workings of planet earth comes from our analysis of seismic activity but it's not that easy to do the same on other planets with inhospitable surface conditions like Venus. So how can we work around this problem? According to NASA JPL and some students from CalTech, balloons are the answer! The team was able to prove that weather balloons with barometers (instruments that gauge pressure differences) could detect earthquakes miles away. (16:00) - Increasing OLED Efficiency: OLED screens are becoming the standard for phones, TVs, and monitors; however, about 80% of the light produced by these screens actually ends up trapped inside the devices leading to drastic decreases in overall efficiency. Researchers from University of Michigan have found a way to liberate ~20% of the trapped light by making some modifications to the electrodes on either side of the light emitters and using an index-matching fluid to prevent light getting trapped by the outer glass layer.

If this was a chemistry class, you'd never think playing lead guitar in a rock band would mix with having a doctorate in Nanoscience. That's what makes Dr. Taylor Mabe so unique. His discussion in this episode touches on the element of timing in your career, as well as how being in bands prepared him for running a business based in science and technology. For anyone interested in launching a career in those fields, Dr. Mabe recommends the National Science Foundation i-Corps program, found here: https://www.nsf.gov/ You can also check out his new music at The Call Girl at: www.thecallgirlband.com

Great science comes in teeny tinsy teeny packages, as the gang discovers when Dr. Roshan Achal does his level best to explain atomic-scale manufacturing. Helping him assemble big ideas atom-by-atom, we have Ronald Dario, Allie Entwistle, and Mark Chavez on the line. Let's get small.Discovery the glory of ones and zeros with us on the

In this episode, Blake flies solo when interviewing the CEO of Elementa Oral Care and the host of The Biofilm Factor podcast, Dr. Ryan Nolan.  Blake and Ryan discuss Dr. Nolan's background in science and the struggles of building a start-up.  Later in the episode they discuss the struggles of going against big brands and disrupting an industry.  If you are curious about how start-ups work, entrepreneurship, the dental industry or you're just a nerd, you don't want to miss this episode!